HCPCS Level II drug code
J0135 — Injection, adalimumab, 20 mg
In short
J0135 is the HCPCS Level II code for injection, adalimumab, 20 mg. One billing unit is 20 mg.
Code
Med-Code curatedHCPCS codeJ0135
Billing unit20 mg
- Descriptor
- Injection, adalimumab, 20 mg
- Code set
- HCPCS Level II, maintained by CMS
- Category
- Autoimmune / Anti-TNF
Units and claim line
Units = dose given ÷ 20 mg. For example, 2000 mg is 100 units. Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
Drugs mapped to J0135
- AdalimumabGenericAdalimumab is usually self-administered and dispensed through a pharmacy benefit. Adalimumab biosimilars are listed under their own names.
- HumiraBrandAdalimumab is usually self-administered and dispensed through a pharmacy benefit. Adalimumab biosimilars are listed under their own names.
FDA-listed products billed under J0135
Finished products in the FDA NDC Directory whose brand or single active ingredient, and route, match this code’s entry.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Adalimumabadalimumab-adaz | Adalimumab 80 mg/.8mL | Injection, SolutionSubcutaneous | Sandoz Inc | 61314-325 |
| Adalimumabadalimumab-adaz | Adalimumab 40 mg/.4mL | Injection, SolutionSubcutaneous | Sandoz Inc | 61314-327 |
| Adalimumabadalimumab-adaz | Adalimumab 20 mg/.2mL | Injection, SolutionSubcutaneous | Sandoz Inc | 61314-332 |
| Adalimumabadalimumab-adaz | Adalimumab 10 mg/.1mL | Injection, SolutionSubcutaneous | Sandoz Inc | 61314-391 |
| Adalimumab-bwwd | Adalimumab 40 mg/.4mL | SolutionSubcutaneous | Cordavis Limited | 83457-186 |
| Adalimumab-bwwd | Adalimumab 40 mg/.4mL | SolutionSubcutaneous | Cordavis Limited | 83457-187 |
| Amjevitaadalimumab-atto | Adalimumab 20 mg/.2mL | InjectionSubcutaneous | Amgen, Inc | 55513-399 |
| Amjevitaadalimumab-atto | Adalimumab 40 mg/.8mL | InjectionSubcutaneous | Amgen, Inc | 55513-400 |
| Amjevitaadalimumab-atto | Adalimumab 40 mg/.8mL | InjectionSubcutaneous | Amgen, Inc | 55513-410 |
| Amjevitaadalimumab-atto | Adalimumab 20 mg/.4mL | InjectionSubcutaneous | Amgen, Inc | 55513-411 |
| Amjevitaadalimumab-atto | Adalimumab 10 mg/.2mL | InjectionSubcutaneous | Amgen, Inc | 55513-413 |
| Amjevitaadalimumab-atto | Adalimumab 40 mg/.4mL | InjectionSubcutaneous | Amgen, Inc | 55513-479 |
| Amjevitaadalimumab-atto | Adalimumab 80 mg/.8mL | InjectionSubcutaneous | Amgen, Inc | 55513-480 |
| Amjevitaadalimumab-atto | Adalimumab 80 mg/.8mL | InjectionSubcutaneous | Amgen, Inc | 55513-481 |
| Amjevitaadalimumab-atto | Adalimumab 40 mg/.4mL | InjectionSubcutaneous | Amgen, Inc | 55513-482 |
| Amjevitaadalimumab-atto | Adalimumab 20 mg/.2mL | InjectionSubcutaneous | Amgen USA Inc. | 72511-399 |
| Amjevitaadalimumab-atto | Adalimumab 40 mg/.8mL | InjectionSubcutaneous | Amgen USA Inc. | 72511-400 |
| Amjevitaadalimumab-atto | Adalimumab 40 mg/.4mL | InjectionSubcutaneous | Amgen USA Inc. | 72511-479 |
| Amjevitaadalimumab-atto | Adalimumab 80 mg/.8mL | InjectionSubcutaneous | Amgen USA Inc. | 72511-481 |
| Amjevitaadalimumab-atto | Adalimumab 40 mg/.4mL | InjectionSubcutaneous | Amgen USA Inc. | 72511-482 |
| Amjevitaadalimumab-atto | Adalimumab 20 mg/.2mL | InjectionSubcutaneous | Nuvaila Limited | 84612-399 |
| Amjevitaadalimumab-atto | Adalimumab 40 mg/.4mL | InjectionSubcutaneous | Nuvaila Limited | 84612-479 |
| Amjevitaadalimumab-atto | Adalimumab 80 mg/.8mL | InjectionSubcutaneous | Nuvaila Limited | 84612-481 |
| Amjevitaadalimumab-atto | Adalimumab 40 mg/.4mL | InjectionSubcutaneous | Nuvaila Limited | 84612-482 |
| Hadlimaadalimumab-bwwd | Adalimumab 40 mg/.8mL | SolutionSubcutaneous | A-S Medication Solutions | 50090-6705 |
All NDCs for these drugs
J0135: common questions
- Is J0135 a CPT code?
- No. J0135 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What is one billing unit of J0135?
- One unit of J0135 is 20 mg, as stated in the code's descriptor. Units to report = dose given ÷ 20 mg. J-code billing units.